Fundz

Tract Bio Appoints Chris Galloway as Chief Medical and Development Officer

PRIVATEJul 15, 2025

Position

Chief Medical Officer

Company

Tract Bio

Chris Galloway
BostonBiotechnologyHealth CareTherapeutics

Description

Tract Bio has appointed Chris Galloway as its new chief medical and development officer. This strategic move comes as the Boston-based biotech prepares for an investigational new drug filing within the next 18 months.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Tract Bio, and when

A new leader at Tract Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Tract Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tract Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tract Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tract Bio

Location

Boston, Massachusetts, United States

About

Tract Bio is a US biotech company focused on developing treatments for oncology and inflammatory conditions. The company is preparing for an investigational new drug filing for its lead oncology candidate, TP-101. With a strong pipeline, Tract Bio aims to address cancers resistant to standard therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tract Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Tract Bio's next move

Learn about Strategic plan

Tract Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.